MRNA vs NXPLW
Moderna Inc (MRNA) versus NextPlat Corp (NXPLW) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
NextPlat Corp (NXPLW) common stock listed on NASDAQ.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
NXPLW does not have a complete income-statement cache yet.
MRNA currently screens at market cap $24.52B. NXPLW currently screens at market cap $0.
Not investment advice. Open the MRNA and NXPLW stock pages for the full models.
Not investment advice.